QuatRx Pharmaceuticals Announces Merger With Hormos Medical

QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company developing new therapies to treat cardiovascular, metabolic and endocrine diseases, has announced a merger with Hormos Medical Corporation, a biopharmaceutical company based in Turku, Finland, focused on research and development of products to treat endocrine disorders associated with aging. Under the terms of the transaction, Hormos will become a wholly-owned subsidiary of QuatRx.

Yahoo News (http://biz.yahoo.com/prnews/050516/dem008.html?.v=10)